Healthcare | September 24, 2022
Madhavbaug plans to foray in UAE, Europe & US
To set up 50 lifestyle modification centres across the UAE in the next 24 months
To set up 50 lifestyle modification centres across the UAE in the next 24 months
Diclofenac Sodium Topical Solution USP, 2% w/w (RLD Pennsaid) had estimated annual sales of US $484 million in the US
One in two women with advanced ovarian cancer has an HRD-positive tumor
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Charsire Biotechnology Corp. has successfully developed a revolutionary new drug (BAC) for Alzheimer's disease
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Subscribe To Our Newsletter & Stay Updated
